(PRAM) Amundi Prime Emerging - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU2300295123 • Global Emerging Markets Equity

PRAM: Equities, Stocks, Emerging Markets

Amundi Prime Emerging Markets UCITS ETF DR (C) is an exchange-traded fund listed on XETRA under the ticker symbol PRAM. It is domiciled in Germany and focuses on providing exposure to global emerging markets equities. The fund tracks the Morningstar EM TME NR USD index, offering investors access to a diversified portfolio of emerging market stocks.

From a technical perspective, PRAM has shown a recent price of 17.80, with short-term moving averages indicating potential resistance. The SMA 20 at 18.41 and SMA 50 at 18.19 suggest the fund is currently below its recent averages, while the SMA 200 at 17.69 indicates longer-term support. The ATR of 0.19 reflects relatively low volatility in recent trading activity, with an average daily volume of 5,823 shares over the past 20 days.

Fundamentally, the ETF manages assets under management (AUM) of 28.35 million EUR, positioning it as a modestly sized fund within the emerging markets equity category. This size allows for efficient tracking of the underlying index while maintaining liquidity for investors.

3-month forecast:

Based on and , the ETF is expected to trade within a narrow range. The SMA 20 and SMA 50 are above the current price, suggesting potential resistance at 18.19-18.41. Support is likely at 17.69, based on the SMA 200. The ATR of 0.19 indicates low volatility, with expected price fluctuations within a 0.38 range (17.42 - 18.20) over the next three months. The AUM of 28.35M EUR suggests stable liquidity, supporting the funds ability to track its index without significant deviation.

Additional Sources for PRAM ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

PRAM ETF Overview

Market Cap in USD 31m
Category Global Emerging Markets Equity
TER 0.10%
IPO / Inception 2021-09-14

PRAM ETF Ratings

Growth 5y 11.6%
Fundamental -
Dividend 0.0%
Rel. Strength Industry -14.1
Analysts -
Fair Price Momentum 16.27 EUR
Fair Price DCF -

PRAM Dividends

No Dividends Paid

PRAM Growth Ratios

Growth Correlation 3m 8.4%
Growth Correlation 12m 79.6%
Growth Correlation 5y 8.9%
CAGR 5y -2.37%
CAGR/Max DD 5y -0.08
Sharpe Ratio 12m 0.62
Alpha 2.66
Beta 0.55
Volatility 19.03%
Current Volume 8.4k
Average Volume 20d 4.4k
What is the price of PRAM stocks?
As of March 15, 2025, the stock is trading at EUR 17.84 with a total of 8,402 shares traded.
Over the past week, the price has changed by +0.24%, over one month by -3.28%, over three months by -1.77% and over the past year by +9.46%.
Is Amundi Prime Emerging a good stock to buy?
Neither. Based on ValueRay Analyses, Amundi Prime Emerging is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 11.60 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PRAM as of March 2025 is 16.27. This means that PRAM is currently overvalued and has a potential downside of -8.8%.
Is PRAM a buy, sell or hold?
Amundi Prime Emerging has no consensus analysts rating.
What are the forecast for PRAM stock price target?
According to ValueRays Forecast Model, PRAM Amundi Prime Emerging will be worth about 18.1 in March 2026. The stock is currently trading at 17.84. This means that the stock has a potential upside of +1.23%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 18.1 1.2%